GROUP – A (LAQ-15 MARKS) 1. A person is brought to the emergency at 10 pm with pain abdomen. History reveals that he had such episodes on and off for last one month along with constipation. He also complains that there is weakness of his hands and feets and he was having cramps and tremors & numbness over hands and legs before the actual weakness started. On physical examination, his blood pressure was raised along with facial pallor. Further enquiry revealed that he is working in a paint industry for last 30 years. i. What poisoning may cause the above noted presentation ? ii. Describe the usual and expected hematological features in a case of such poisoning ? iii. How will you proceed to conifrm the diagnosis and manage such a case of poisoning ? [2+4+(4+5)] [ESIC JOKA] 2. A worker of a battery industry is hospitalized with a history of sudden onset dysphagia, pain abdomen, vomiting, constipation & headache. On examination, he has anemia, fine tremors, & wrist drop. Name the probable poison. Mention another 3 common sources of this poison causing human exposure. What are the expected findings in a peripheral blood smear? Mention the biochemical markers in blood & urine. What is the reason behind anemia in this case? Mention the other clinical manifestations of chronic poisoning with this poison. Mention the specific therapeutic measure for acute involvement of the central nervous system in this substance poisoning. (2+2.5+1.5+2+2 = 10) [JNM] 3. One labour was admitted at a peripheral Medical College with history of fatigue, irritability and weight loss. Clinical examination revealed a blue line over his gum and wrist drop. What are the differential diagnoses of this case? What are the other clinical features of this case? How will you confirm the diagnosis? How will you manage this case? (2 + 5 + 3 + 5 = 15) [NRS] 4. During autopsy, an autopsy surgeon found evidence of bluish discoloration of stomach & duodenum mucosa with yellowish discoloration of skin. a) What may be the suspected cause of death in this case? b) What are the clinical signs & symptoms of this case? c) Enumerate the specific treatment of this case. d) Mention the method of preservation of viscera in this case. (1+3+3+3=10) [RGKAR] 5. A person presented in emergency at 10 pm with pain abdomen. History reveals that he had such episodes on and off for last one month. He also complains that there is weakness of his hands and feet and he was having tremors, numbness and cramps over hands and legs before the actual weakness starts. On enquiry it was found that he is working in a paint industry for last 30 years. What are the different causes of chronic lead poisoning? Describe the clinical features of chronic lead poisoning? Describe the hematological findings in a case of Chronic lead poisoning? Outline the management of a case of chronic lead poisoning. (2+5+3+5=15) [MJNMCH] 6. A male worker working in an industry since long time presented to the emergency with complain of diffuse skin pigmentation over the back of body along with features of wrist and foot drop. a) What is your provisional diagnosis? b) What are the investigation to be done for confirmation of diagnosis? c) Write down the steps of management. d) Describe the autopsy findings you will get in this case. (2+4+6+3=15) [JALPAIGURI] 7. A 30-year-old painter by occupation, presents to the Medicine OPD with history of vomiting headache, visual disturbances, restlessness and convulsion. On examination, patient is anaemic with facial paleness, blue line on the gums and left wrist drop. a) Explain the various clinical manifestations of the suspected poison. b) Discuss in detail about treatment protocol in a case of acute poisoning by the same. c) What are the samples you will preserve during autopsy in such a case? (5+5+5=15) [CMSDH]

Reading File
All 7 questions are about Lead Poisoning - a major forensic medicine and toxicology topic. Let me query the medical library in parallel for comprehensive coverage.
Finding Sources
Finding Sources
Excellent - found key sources. Now let me read the most authoritative forensic medicine textbook sections in parallel:
Reading File
Reading File
Reading File
Excellent data. Now let me read more sections on hematological features, management, autopsy findings, and treatment:
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have comprehensive information to answer all 7 questions. Let me also quickly check the arsenic section since Q4 mentions bluish discoloration of stomach/duodenum with yellow skin - which could be arsenic rather than lead:
Finding Sources
Reading File
Now I have all the information needed. Let me also quickly check the arsenic autopsy findings since Q4 mentions yellow skin (jaundice) + bluish stomach - this is a classic arsenic autopsy picture:
Finding Sources
I have enough information. Now let me write the comprehensive answers for all 7 questions.

LEAD POISONING - Complete Answers to All 7 Questions

All seven questions revolve around Lead Poisoning (Plumbism). Q4 describes autopsy findings consistent with arsenic (bluish stomach + yellowish skin/jaundice), which is addressed separately below.

QUESTION 1 (ESIC JOKA) - [2+4+(4+5)]

i. What poisoning may cause the above presentation? (2 marks)

Chronic Lead Poisoning (Plumbism)
The clinical triad of:
  • Pain abdomen + constipation (lead colic)
  • Peripheral neuropathy (weakness, tremors, cramps, numbness preceding actual weakness)
  • Raised BP + facial pallor
  • Occupation: paint industry for 30 years (classic lead exposure source)
...is pathognomonic of chronic lead poisoning.

ii. Hematological Features of Lead Poisoning (4 marks)

Lead is a potent inhibitor of the heme synthesis pathway, producing characteristic blood findings:
1. Peripheral Blood Smear Changes:
  • Basophilic stippling (punctate basophilia) - pathognomonic of plumbism. Discrete dark-blue pinhead-sized particles in the cytoplasm of RBCs, seen at blood lead levels of 60-80 μg/100 mL. Due to aggregation/clumping of ribosomes.
  • Polychromasia and polychromatophilia (early stages)
  • Reticulocytosis - compensatory increase
  • Poikilocytosis and anisocytosis
  • Nucleated red cells (sideroblasts)
  • Decreased polymorphonuclear cells and platelets
  • Under UV light: 75-100% fluorescent red cells due to increased protoporphyrin
2. Type of Anaemia:
  • Early stages: Polycythemia with polychromatophilia
  • Late stages: Microcytic or normocytic anaemia (NOT macrocytic)
3. Mechanism of Anaemia:
  • Inhibition of heme synthesis: Lead inhibits delta-aminolevulinic acid dehydratase (ALAD) and ferrochelatase, blocking incorporation of iron into protoporphyrin
  • Decreased RBC lifespan: RBCs become mechanically more fragile → shortened survival
4. Porphyrin Disturbances:
  • Elevated erythrocyte protoporphyrin (EP) / zinc protoporphyrin (ZPP) in blood
  • Increased coproporphyrin III (CPIII) in urine (>150 μg/L) - detectable as reddish fluorescence under UV lamp
  • Delta-aminolevulinic acid (ALA) in urine >5 mg/L indicates lead absorption

iii. Confirmation of Diagnosis + Management (4+5 marks)

A. Confirming the Diagnosis (4 marks):
  1. History: Occupational exposure (paint industry) for 30 years; symptoms of colic, constipation, neuropathy
  2. Clinical Features: Blue gum line (Burtonian/Lead line), facial pallor, hypertension, wrist drop / peripheral neuropathy
  3. Laboratory Tests:
    • Blood lead level (BLL): Normal = 0.03 mg/100 mL; BLL >70 μg/100 mL = clinical symptoms; 0.1-0.6 mg/100 mL = diagnostic of poisoning
    • Urine lead: >0.8 mg/L (normal: 0.2-0.8 mg/L)
    • ALA in urine: >5 mg/L indicates lead absorption
    • Coproporphyrin in urine (CPU): >150 μg/L in exposed individuals
    • Peripheral blood smear: Basophilic stippling - sensitive and pathognomonic
    • X-ray of long bones (esp. in children): Radio-opaque "lead lines" at metaphyses
  4. Chelation challenge test (EDTA mobilization test): Increased urinary lead excretion after EDTA administration confirms significant body burden
B. Management (5 marks):
Step 1 - Remove from exposure: Immediate removal from the paint industry / source of exposure
Step 2 - Decontamination/Prevent further absorption:
  • Gastric lavage with 1% magnesium sulphate or sodium sulphate
  • Oral magnesium or sodium sulphate (8-12 g) - converts unabsorbed lead to insoluble lead sulphate
Step 3 - Supportive Treatment:
  • Calcium gluconate IV - for colic relief
  • Morphine or atropine - for severe pain
  • High calorie diet; 3 pints of milk/day (alkalosis to fix lead in bones)
  • Thiamine 10-50 mg/kg - helps neurological manifestations
Step 4 - Chelation Therapy (based on BLL and severity):
SeverityBlood Lead LevelTreatment
Severe with encephalopathy>70 μg/100 mLBAL 4 mg/kg IM q4h + CaNa₂EDTA 75 mg/kg/day IV
Severe without encephalopathy>70 μg/100 mLBAL + EDTA; stop BAL when BLL <40 μg/100 mL
Moderate45-75 μg/100 mLEDTA alone 50 mg/kg/day
Mild20-35 μg/100 mLD-penicillamine or DMSA (oral)
  • CaNa₂EDTA (Calcium Disodium Versenate): 5 mL of 20% solution in 250-500 mL NS/5%D, slow IV drip over 1 hour, twice daily for 5 days. Increases urinary lead excretion 50-fold
  • BAL (British Anti-Lewisite/Dimercaprol): 4 mg/kg IM q4h. Give at least 4 hours BEFORE EDTA. Chelates lead both intracellularly and extracellularly. Drug of choice with renal impairment
  • D-Penicillamine: 10 mg/kg/day oral; useful in children
  • DMSA (Succimer/Dimercaptosuccinic acid): 10 mg/kg three times daily for 20 days; more effective and less toxic than penicillamine
Step 5 - Prevention of recurrence:
  • Adequate ventilation and industrial hygiene
  • Regular BLL monitoring of workers
  • Workers should be removed if BLL persistently elevated

QUESTION 2 (JNM) - (2+2.5+1.5+2+2 = 10)

Name the probable poison (2 marks)

Lead (Pb) - Chronic Lead Poisoning
History: battery industry worker + dysphagia, abdominal pain, vomiting, constipation, headache + anemia + fine tremors + wrist drop = classic plumbism.

3 Other Common Sources of Lead Exposure (2.5 marks)

  1. Paint industry - inhalation of lead dust/fumes (most common occupational source)
  2. Gasoline/petroleum - environmental lead from automobile exhaust (leaded petrol)
  3. Drinking water - from water stored in lead pipes or lead-lined cisterns
  4. Tinned food - contaminated through lead solder
  5. Printing/compositing industry, rubber industry, lead smelters, glass manufacturing
  6. Vermilion (sindoor) - applied to scalp by Hindu married women; absorbed through skin with hair oil

Expected Peripheral Blood Smear Findings + Biochemical Markers (1.5 marks)

Blood smear:
  • Basophilic stippling (punctate basophilia) - pathognomonic
  • Reticulocytosis, polychromasia, anisocytosis, poikilocytosis
  • Nucleated RBCs (sideroblasts), decreased polymorphs and platelets
Biochemical markers:
  • Blood: BLL >70 μg/100 mL (normal <0.03 mg/100 mL); elevated erythrocyte protoporphyrin (EP)/ZPP
  • Urine: ALA (delta-aminolevulinic acid) >5 mg/L; Coproporphyrin III >150 μg/L; Lead >0.8 mg/L

Reason Behind Anaemia (2 marks)

Two mechanisms:
  1. Inhibition of heme synthesis: Lead inhibits ALA dehydratase and ferrochelatase, blocking incorporation of iron into protoporphyrin IX to form heme. This causes iron to accumulate in RBC mitochondria as ringed sideroblasts.
  2. Decreased RBC lifespan: Lead makes RBCs mechanically more fragile, shortening their survival time (hemolytic component).
  3. Inhibition of globin synthesis also contributes.
Result: Microcytic/normocytic anemia with sideroblasts.

Other Clinical Manifestations of Chronic Lead Poisoning (2 marks)

  • Facial pallor (earliest and most consistent sign, due to vasospasm around mouth)
  • Lead line / Burtonian line: Bluish-black line on gums (due to lead sulphide formation from H₂S)
  • Lead colic: Severe colicky abdominal pain, usually nocturnal, in 85% cases; constipation
  • Lead palsy: Wrist drop (radial nerve; extensor muscle weakness), foot drop (anterior tibial muscles)
  • Lead encephalopathy: Insomnia, headache, vomiting, restlessness, delirium, convulsions, coma
  • Cardiovascular/renal: Hypertension, arteriolar degeneration, chronic interstitial nephritis
  • Reproductive: Menstrual disturbances, infertility, abortion at 3-6 months, fetal abnormalities
  • Other: Anorexia, weight loss, alopecia, vertigo, metallic taste

Specific Therapeutic Measure for Acute CNS Involvement (2 marks)

BAL (British Anti-Lewisite / Dimercaprol) + CaNa₂EDTA combination:
  • BAL: 4 mg/kg IM every 4 hours (in children). Repeat until BLL falls below 40 μg/100 mL. Given FIRST, at least 4 hours before EDTA.
  • CaNa₂EDTA: 75 mg/kg/day as IV infusion (for encephalopathy). Reduce to 50 mg/kg/day as condition improves. Continue until patient is asymptomatic.
  • Then transition to oral chelation: D-penicillamine 10 mg/kg/day OR DMSA (succimer) 10 mg/kg TDS for 20 days.
  • Supportive: Control seizures with diazepam/phenobarbitone; manage cerebral edema; corticosteroids may be used for brain edema.

QUESTION 3 (NRS) - (2+5+3+5 = 15)

Differential Diagnoses (2 marks)

Key features: Fatigue, irritability, weight loss + blue line on gums + wrist drop
  1. Chronic Lead Poisoning - most likely (Burton's line + wrist drop)
  2. Chronic Mercury Poisoning (Mercurialism) - can cause gum discoloration, tremors, neuropsychiatric features (but blue line is characteristic of lead)
  3. Chronic Arsenic Poisoning - fatigue, weight loss, neuropathy (but features like Mees' lines, skin pigmentation more typical)
  4. Alcoholic peripheral neuropathy - wrist/foot drop but no gum line
  5. Other heavy metal poisoning - bismuth, copper can cause gum line

Other Clinical Features (5 marks)

A. General/Systemic:
  • Facial pallor (especially around mouth, due to vasospasm) - earliest and most consistent sign
  • Anorexia, emaciation, weight loss, alopecia
  • Metallic/sweetish taste in mouth
B. Gastrointestinal:
  • Lead colic - severe colicky pain, usually nocturnal, occurring in 85% cases; abdominal wall rigid/contracted; relieved by pressure
  • Obstinate constipation (constant feature)
  • Vomiting and nausea may occur
C. Hematological:
  • Anaemia (microcytic/normocytic), basophilic stippling
  • Facial pallor
D. Neurological - Lead Palsy:
  • Tremors, cramps, numbness, hyperesthesia PRECEDE actual weakness
  • Wrist drop (extensor muscles of wrist; radial nerve affected) - commonest
  • Foot drop (anterior tibial muscles affected)
  • Deltoid and biceps may be affected
  • Purely motor paralysis; recovery slow but may be complete
E. Lead Encephalopathy:
  • Insomnia, headache, visual disturbances, irritability, restlessness
  • Delirium, hallucinations, convulsions, coma - can be fatal
  • Present in some form in almost every case
  • More common in children; often irreversible (85% permanent brain damage)
F. Cardiovascular/Renal:
  • Hypertension (vascular constriction)
  • Chronic arteriosclerotic nephritis, interstitial nephritis
G. Reproductive:
  • Menstrual disturbances, sterility, abortion, fetal abnormalities

Confirming the Diagnosis (3 marks)

  1. Detailed occupational history - type and duration of exposure
  2. Blood lead level (BLL):
    • Normal: 0.03 mg/100 mL; BLL >70 μg/100 mL = clinical symptoms
    • Diagnostic in poisoning: 0.1-0.6 mg/100 mL
  3. Urine tests:
    • ALA (aminolevulinic acid): >5 mg/L = significant lead absorption
    • Coproporphyrin III: >150 μg/L (normal <150); detected as reddish fluorescence under UV lamp with acetic acid and ether
    • Urine lead: >0.8 mg/L
  4. Peripheral blood smear: Basophilic stippling, sideroblasts
  5. X-ray long bones (children): Radio-opaque lead lines at metaphyses
  6. Zinc protoporphyrin (ZPP): Elevated (>35 μg/L)

Management (5 marks)

(Same as Q1 management - refer above for full details)
Key points:
  1. Remove from exposure immediately
  2. Prevent further absorption: Gastric lavage (MgSO₄ solution), saline purgative
  3. Supportive: Calcium gluconate IV for colic; high calorie diet with milk; morphine for pain; thiamine for neuropathy
  4. Chelation (as per severity):
    • With encephalopathy: BAL 4 mg/kg IM q4h + CaNa₂EDTA 75 mg/kg/day IV
    • Without encephalopathy but BLL >70: BAL + EDTA; stop BAL when <40 μg/100 mL
    • Moderate (45-75): EDTA alone
    • Mild: Oral D-penicillamine or DMSA
  5. Prevent recurrence: Occupational hygiene, ventilation, periodic medical screening
  6. Lead poisoning is a notifiable and compensatable disease in India (since 1924)

QUESTION 4 (RGKAR) - (1+3+3+3 = 10)

a. Suspected Cause of Death (1 mark)

Bluish discoloration of stomach/duodenum mucosa + yellowish skin discoloration at autopsy:
  • Yellowish skin = jaundice (hepatic damage)
  • Bluish/dark discoloration of stomach and duodenum = characteristic of Arsenic Poisoning
Suspected cause: Acute Arsenic Poisoning
Note: The bluish-grey discoloration of the gastric and duodenal mucosa with yellowish jaundice is the classic autopsy picture of arsenic. (In lead autopsy, the stomach is contracted and thickened, mucosa softened/eroded; the blue line is on the gums.)

b. Clinical Signs and Symptoms (3 marks)

Acute Arsenic Poisoning:
GI Phase (within 30 min - few hours):
  • Metallic/garlic taste in mouth
  • Burning in throat and esophagus
  • Severe nausea and projectile vomiting (rice-water or blood-stained)
  • Profuse watery diarrhea ("rice-water" stools resembling cholera)
  • Violent abdominal cramps and colicky pain
Systemic Phase:
  • Dehydration, hypotension, circulatory collapse
  • Oliguria → anuria, renal failure
  • Jaundice (hepatic damage - yellow skin)
  • Muscle cramps and weakness
  • Mees' lines (transverse white lines on fingernails - in chronic cases)
  • CNS: Headache, convulsions, coma
Chronic/Subacute:
  • Skin: Diffuse hyperpigmentation ("rain-drop pigmentation"), keratosis of palms/soles
  • Peripheral neuropathy: "Stocking and glove" sensory neuropathy
  • Alopecia, Mees' lines
  • Marrow suppression, pancytopenia

c. Specific Treatment (3 marks)

  1. Remove from source - stop exposure immediately
  2. Decontamination:
    • Gastric lavage with warm water or freshly prepared ferric hydroxide (antidote for arsenic)
    • Activated charcoal
    • Saline cathartic
  3. Specific Antidote - Chelation Therapy:
    • BAL (Dimercaprol): Drug of choice. 3-5 mg/kg IM every 4 hours for 2 days, then 2-3 mg/kg IM q6h for 2 more days, then 2-3 mg/kg IM daily for 7 days
    • DMSA (Succimer): 10 mg/kg oral TDS for 5 days - safer alternative
    • D-penicillamine: 250 mg oral QID as follow-up chelation
  4. Supportive:
    • IV fluids and electrolyte replacement (manage dehydration/shock)
    • Treat renal failure (dialysis if needed)
    • Manage hepatic failure
    • Pain relief

d. Method of Preservation of Viscera (3 marks)

In cases of suspected metallic/inorganic poisoning (including arsenic), the standard method is Saturated Common Salt (NaCl) solution - NOT formalin (which is organic).
Organs to be preserved and method:
Organ/SampleContainerPreservative
Stomach + contentsWide-mouth glass jarSaturated NaCl solution (30%)
Portion of small intestine (jejunum + ileum) + contentsSeparate glass jarSaturated NaCl solution
Portion of liver (250 g)Glass jarSaturated NaCl solution
One kidney (half)Glass jarSaturated NaCl solution
Urine (100 mL)Clean glass bottleNo preservative / plain
Blood (50 mL)Clean bottleSodium fluoride (NaF) as preservative
Hair and nailsPaper envelopeNone (dry)
Bone (rib/femur segment)Dry containerNone
Key rule: Use glass containers (not plastic), clean and new (to avoid contamination). Each container sealed and labeled. No formalin as it is an organic preservative and interferes with chemical analysis. Saturated salt solution is used for all metallic poisons.

QUESTION 5 (MJNMCH) - (2+5+3+5 = 15)

Different Causes / Sources of Chronic Lead Poisoning (2 marks)

Occupational Sources:
  1. Paint industry (pigments - lead carbonate/white lead, red lead)
  2. Battery industry (lead plates)
  3. Printing and compositing industry
  4. Plumbing industry (lead pipes)
  5. Glass and enamel manufacture
  6. Lead smelting, rubber industry
  7. Electric light workers
  8. Petrol/gasoline industry (lead tetraethyl)
Non-Occupational Sources:
  1. Drinking water from lead pipes or lead-lined cisterns
  2. Tinned food contaminated with lead from solder
  3. Ghee stored in tin-lined brass/copper vessels (oleate of lead formed)
  4. Sindoor/vermilion applied to scalp by Hindu women (absorbed through skin with hair oil)
  5. Children chewing/licking lead-painted toys, walls, furniture
  6. Environmental pollution from automobile exhaust (leaded petrol)
  7. Food cooked in lead vessels

Clinical Features of Chronic Lead Poisoning (5 marks)

1. Facial Pallor
  • The earliest and most consistent sign
  • Particularly around the mouth
  • Independent of degree of anaemia
  • Due to vasospasm
2. Anaemia
  • Occurs at BLL 70-80 μg/100 mL
  • Microcytic or normocytic (not macrocytic)
  • Associated features: basophilic stippling, reticulocytosis, poikilocytosis
3. Lead Line (Burtonian Line)
  • Present in 50-70% of cases
  • Blue/bluish-black line on gums at the junction with teeth
  • Only near dirty/carious teeth, especially in upper jaw
  • Appears within a week of exposure
  • Due to lead sulphide formation from H₂S (decomposed food bacteria in mouth)
  • Metallic/sweetish taste in mouth
4. Colic and Constipation ("Dry belly-ache")
  • Late symptom; occurs in 85% of cases
  • Intestinal, ureteral, uterine colic
  • Usually nocturnal, very severe
  • Abdominal wall rigid and contracted; relief by firm pressure
  • Attacks last few minutes, recur over days/weeks
  • Constipation is constant; diarrhea and vomiting may occur
5. Lead Palsy
  • Late feature, in <10% cases
  • Tremors, hyperesthesia, numbness, cramps PRECEDE actual weakness
  • Commonest: Wrist drop (extensor muscles; radial nerve; C7)
  • Others: Foot drop (anterior tibial muscles), deltoid, biceps
  • Purely motor paralysis; axonal degeneration of nerve with muscle atrophy
  • Recovery is slow but may be complete
6. Lead Encephalopathy
  • Present in almost all cases in some form
  • More common in children
  • Symptoms: Insomnia, headache, vomiting, visual disturbances, irritability, restlessness, delirium, hallucinations, convulsions, coma → death
  • Usually irreversible; 85% permanent brain damage; 25% mortality
7. Cardiovascular and Renal
  • Hypertension (vascular constriction)
  • Arteriolar degeneration, arteriosclerosis
  • Chronic interstitial nephritis, nephrosclerosis
8. Reproductive System
  • Menstrual irregularities, sterility
  • Abortion at 3-6 months of gestation
  • Fetal abnormalities, stillbirths
9. Miscellaneous
  • Coproporphyrinuria (porphyrin excreted in urine ~500 μg/day)
  • Anorexia, emaciation, alopecia, vertigo

Hematological Findings in Chronic Lead Poisoning (3 marks)

  1. Basophilic Stippling (Punctate Basophilia) - pathognomonic
    • Discrete dark-blue pinhead-size particles in RBC cytoplasm
    • Seen at BLL 60-80 μg/100 mL
    • Due to aggregation of ribosomes (ribosomal RNA) - lead inhibits pyrimidine-5'-nucleotidase
    • Under UV light: 75-100% fluorescent cells due to increased protoporphyrin
  2. Anaemia: Microcytic/normocytic (not macrocytic)
    • Early: Polycythemia with polychromatophilia
    • Late: Anaemia with reticulocytosis
  3. Reticulocytosis - compensatory response
  4. Morphological changes: Poikilocytosis, anisocytosis, polychromasia
  5. Nucleated RBCs / Sideroblasts (ringed sideroblasts in bone marrow)
  6. Decreased polymorphs and platelets
  7. Elevated erythrocyte protoporphyrin (EP) / Zinc protoporphyrin (ZPP) - elevated in blood
  8. Mechanism of anaemia:
    • Lead inhibits ALAD and ferrochelatase → block in heme synthesis
    • Decreased RBC survival (mechanical fragility)

Management of Chronic Lead Poisoning (5 marks)

(Refer to Q1 management above - complete details provided)
Summary outline:
  1. Remove from exposure (workplace)
  2. Decontamination - saline purgative/lavage
  3. Alkaline diet - milk, calcium gluconate IV (immobilizes lead in bones)
  4. Chelation therapy based on BLL:
    • Encephalopathy: BAL + EDTA IV
    • Severe (no encephalopathy): BAL + EDTA
    • Moderate: EDTA alone
    • Mild: D-penicillamine oral / DMSA oral
  5. Symptomatic: Ca-gluconate for colic, thiamine for neurology, morphine for pain
  6. Occupational rehabilitation + periodic monitoring
  7. Notifiable disease in India

QUESTION 6 (JALPAIGURI) - (2+4+6+3 = 15)

a. Provisional Diagnosis (2 marks)

Chronic Lead Poisoning (Plumbism) with Arsenic poisoning also in differential
The features pointing to lead:
  • Long industrial exposure
  • Wrist drop and foot drop (lead palsy)
The feature of diffuse skin pigmentation over back of body is more suggestive of Chronic Arsenic Poisoning ("rain-drop pigmentation" / melanosis). However, combined with wrist drop and foot drop from industrial exposure, this may also suggest combined or arsenic poisoning.
Most likely: Chronic Arsenic Poisoning (diffuse pigmentation is pathognomonic of arsenic, not lead)
Alternative: Chronic Lead Poisoning (wrist/foot drop) - but pigmentation is less typical.

b. Investigations for Confirmation (4 marks)

For Arsenic:
  1. Urine arsenic: >50 μg/L (normal <50 μg/L); >1000 μg/L in acute poisoning
  2. Blood arsenic level: Elevated
  3. Hair and nail arsenic: Mees' bands on nails; hair arsenic (Reinsch's test, atomic absorption spectroscopy)
  4. Urine: ALA, coproporphyrins (if lead component)
Confirming peripheral neuropathy:
  • Nerve conduction velocity (NCV) studies
  • Electromyography (EMG)
Blood tests:
  • CBC: Pancytopenia (arsenic), anemia + basophilic stippling (lead)
  • LFTs, RFTs (liver/kidney involvement)
  • Blood lead level, ZPP
Imaging:
  • X-ray long bones: Lead lines if lead
  • Chest X-ray
Skin biopsy: Melanocyte hyperactivity in arsenic

c. Steps of Management (6 marks)

Step 1 - Remove from exposure: Immediate transfer away from the industry; sick leave
Step 2 - Decontamination:
  • If recent ingestion: Gastric lavage
  • Activated charcoal
  • Saline cathartic (MgSO₄)
Step 3 - Specific Chelation Therapy:
If Arsenic:
  • BAL (Dimercaprol): 3-5 mg/kg IM q4h × 2 days → 2-3 mg/kg IM q6h × 2 days → 2-3 mg/kg/day for 7 days
  • DMSA (Succimer): 10 mg/kg orally TDS × 5 days (safer, fewer side effects)
  • D-penicillamine: 250 mg oral QID as follow-up
If Lead:
  • BAL + EDTA (as per BLL-guided protocol above)
Step 4 - Supportive Treatment:
  • IV fluid and electrolyte replacement
  • Analgesics for pain
  • Anticonvulsants if seizures (diazepam)
  • Calcium gluconate IV for colic
  • Thiamine for neuropathy
  • Treatment of hepatic/renal failure
  • Corticosteroids if encephalopathy/cerebral edema
Step 5 - Symptomatic Management of Neuropathy:
  • Physiotherapy and rehabilitation for wrist drop/foot drop
  • Wrist/foot splints
  • Vitamin B complex supplementation
Step 6 - Occupational and Legal Measures:
  • Notify appropriate authorities (both lead and arsenic poisoning are notifiable in India)
  • Industrial hygiene assessment
  • Workplace ventilation improvement
  • Protective equipment for co-workers
  • Periodic medical surveillance
Step 7 - Follow-up:
  • Serial blood/urine heavy metal levels
  • NCV monitoring
  • Skin examination (for malignant changes in arsenic - risk of Bowen's disease, squamous cell carcinoma)

d. Autopsy Findings (3 marks)

If Lead Poisoning:
  1. Blue/Burtonian line visible on gums
  2. Stomach and intestines contracted and thickened; gastric mucosa softened, eroded, thickened
  3. Liver and kidneys contracted and shrunken
  4. Brain pale and swollen (cerebral edema in encephalopathy)
  5. Heart hypertrophied with atheroma of aorta
  6. Bone marrow: Hyperplasia of leukoblasts and erythroblasts
  7. Peripheral nerves: Axonal degeneration, muscle atrophy
If Arsenic Poisoning:
  1. Subicteric or jaundiced skin (yellowish discoloration)
  2. Stomach/duodenum mucosa: Bluish-grey/dark discoloration, congested, hemorrhagic erosions
  3. Garlic odor from all organs
  4. Liver: Fatty changes (yellow/pale), centrizonal necrosis
  5. Kidneys: Congested, tubular necrosis
  6. Skin: Pigmentation changes
  7. Hair/nails: Mees' lines on nails; arsenic detectable by Marsh's test
  8. Body well-preserved (arsenic has antiseptic properties - classic "embalming" effect; body preserved even after exhumation)

QUESTION 7 (CMSDH) - (5+5+5 = 15)

(Painter - vomiting, headache, visual disturbances, restlessness, convulsion + anaemia + facial pallor + blue line on gums + left wrist drop)

a. Clinical Manifestations of Lead Poisoning (5 marks)

Summarized systematically:
I. General:
  • Facial pallor (earliest sign, due to vasospasm)
  • Anorexia, weight loss, fatigue, emaciation, alopecia
II. Oral/GI:
  • Blue lead line (Burtonian line) on gums (50-70% cases; upper jaw near carious teeth)
  • Sweetish metallic taste
  • Lead colic (85% cases): severe nocturnal colicky abdominal pain, rigid contracted abdomen
  • Obstinate constipation (constant feature)
III. Hematological:
  • Microcytic/normocytic anaemia
  • Basophilic stippling (pathognomonic)
  • Reticulocytosis, poikilocytosis, sideroblasts
  • Pallor, fatigue
IV. Neurological - Lead Palsy:
  • Tremors, cramps, numbness, hyperesthesia PRECEDE weakness
  • Wrist drop (radial nerve - C7; extensors of wrist)
  • Foot drop (anterior tibial muscle)
  • Deltoid and biceps involvement possible
  • Purely motor; axonal degeneration with muscle atrophy
V. Lead Encephalopathy (most dangerous):
  • Insomnia → Headache → Vomiting → Visual disturbances → Irritability → Restlessness → Delirium → Hallucinations → ConvulsionsComa → Death
  • More common in children; often irreversible (85%)
  • Mortality ~25%
VI. Cardiovascular/Renal:
  • Hypertension (vascular constriction)
  • Interstitial nephritis, nephrosclerosis
  • Arteriosclerosis
VII. Reproductive:
  • Menstrual irregularities, abortion, fetal abnormalities

b. Treatment of Acute Lead Poisoning (5 marks)

Immediate Measures:
  1. Admit to ICU (this is acute encephalopathy with convulsions)
  2. Remove from source of exposure (stop painting/industrial work)
  3. ABC - Airway, Breathing, Circulation
  4. Control seizures: Diazepam IV (0.3 mg/kg) or phenobarbitone
Decontamination: 5. If recent oral ingestion: Gastric lavage with 1% magnesium sulphate 6. Activated charcoal (if recent ingestion <1 hour) 7. MgSO₄ or Na₂SO₄ orally to convert unabsorbed lead to insoluble form
Specific Antidotes - Chelation Therapy (for acute encephalopathy: BLL >70 μg/100 mL): 8. BAL (Dimercaprol) - FIRST LINE for encephalopathy:
  • 4 mg/kg IM every 4 hours
  • Give at LEAST 4 hours before starting EDTA
  • Continue until BLL falls below 40 μg/100 mL
  1. CaNa₂EDTA (Calcium Disodium Versenate):
    • 75 mg/kg/day as IV infusion (severe with encephalopathy)
    • 5 mL of 20% solution in 500 mL NS/5%D, slow IV drip, twice daily × 5 days
    • Reduces to 50 mg/kg/day as condition improves
  2. Sequential oral chelation after IV:
    • D-penicillamine: 10 mg/kg/day
    • OR DMSA (Succimer): 10 mg/kg TDS × 20 days
    • Continue until BLL <15 μg/100 mL
Supportive Measures: 11. Manage cerebral edema: Mannitol, dexamethasone 12. Calcium gluconate IV (10-20 mL of 10%): For colic/spasm 13. High-calorie diet + 3 pints of milk daily (induces alkalosis, immobilizes lead in bones) 14. Morphine/atropine for severe pain 15. Thiamine 10-50 mg/kg for neurological improvement 16. Monitor BP, urine output, renal function, BLL
Treatment Summary Table (from Essentials of FMT, 36th ed):
SeverityBLLTreatment
Severe + encephalopathy>70 μg/100 mLBAL + EDTA IV → then oral DMSA/penicillamine
Severe - encephalopathy>70 μg/100 mLBAL + EDTA; stop BAL at <40
Moderate45-75 μg/100 mLEDTA alone
Mild20-35 μg/100 mLOral DMSA or penicillamine

c. Samples to Preserve During Autopsy (5 marks)

In case of suspected lead (or any inorganic metallic) poisoning:
Preservative Rule: Use SATURATED COMMON SALT (NaCl) solution - NOT formalin
  • Formalin is an organic compound and interferes with chemical analysis
  • All containers must be clean, new, wide-mouth glass (not plastic)
SampleAmountContainerPreservative
Stomach + contentsEntireWide-mouth glass jarSaturated NaCl
Part of small intestine (upper + lower) + contents~30 cm eachSeparate glass jarSaturated NaCl
Part of large intestine + contents~30 cmGlass jarSaturated NaCl
Liver500 g from central portionGlass jarSaturated NaCl
One kidney (whole or half)~150 gGlass jarSaturated NaCl
Portion of brain250-500 gGlass jarSaturated NaCl
Blood50-100 mLClean glass bottleSodium fluoride (NaF) as anticoagulant/preservative
UrineAll availableClean glass bottleNone / plain
HairMultiple strands from occiputPaper envelopeNone (dry)
NailsClippingsPaper envelopeNone (dry)
Bone (femur / rib segment)~5 cm pieceDry glass/cardboardNone
Vitreous humor2 mLPlain vialNone
Additional points:
  • Each container individually labeled: name of deceased, date of PM, case number, organ
  • Sealed with wax/tape and signed by autopsy surgeon
  • Chain of custody maintained
  • Sent to Chemical Examiner (Forensic Science Laboratory)
  • Control blank sent alongside (same container with same preservative, no biological material)

Sources: The Essentials of Forensic Medicine and Toxicology, 36th ed. (KS Narayana Reddy, 2026) | PC Dikshit Textbook of Forensic Medicine and Toxicology | Park's Textbook of Preventive and Social Medicine | KS Narayana Reddy - Chapter 27 (Lead Poisoning)

GROUP – B (SAQ-10 MARKS) 1. A 20-year-old male person is brought to the emergency department with acute loss of hair, garlicky odour from the mouth, and rice water stools. a. Identify the poison causing it. b. What are its clinical features, treatment and post mortem findings? c. Comment on its medico-legal aspects. (1+3+3+2+1 = 10) [IQCITY] 2. A 35 years old male person admitted in your Medical College Hospital in unconscious state for management. No smell of alcohol or any other substances was found from his breath. On examination he was found blue line between teeth and gum. What is your probable diagnosis in this case? How will you proceed to manage of this case? Write other poisons where you will find Blue-Line.(1+6+3=10) [ICARE] 3. A 32-year-old male factory worker, working in a calico printing industry was admitted to the hospital for severe abdominal pain, tingling of extremities, and chronic fatigue. On examination multiple hard warts like growths were observed on the palms and soles. i) What is the probable poison exposure in the above case? ii) Enumerate the signs and symptoms of chronic poisoning for the above poison. iii) Which disease is mimicked during the acute poisoning by this poison and write down few differentiating features between them. (1 + 5 + 4) [GDIMSH] 4. A 45 years male was admitted to BSMCH with intense thirst, severe vomiting. After few hours purging started accompanied by tenesmus & irritation around anus. His breath had a garlicky odour. (i) What is the probable diagnosis? (ii) How will you treat this case? (iii) Discuss the circumstances of the poisoning. (iv) Which natural disease simulates signs & symptoms of this poisoning & how will you differentiate them? (1 + 4 + 2 + 3 = 10) [BSMCH] 5. 30-year-old male is brought to the emergency department with complaints of severe vomiting, abdominal pain, restlessness and difficulty in breathing. On examination, he has signs of shock, garlicky odour in breath, altered sensorium. His relatives reveal that he might have consumed a few tablets kept for storage of food grains approximately 3 hours before developing symptoms. Answer the following: (A) Identify the likely poison and mention its active toxic principle. (2) (B) Describe the mechanism of toxicity. (2) (C) Discuss the clinical features and complications of this poisoning. (2+2) (D) Describe the management of this case. (2) [TGMCH] GROUP – D (E/W-4 MARKS) 1. Foot drop and Burtonian line are features of chronic Lead poisoning. [MLDMCH] 2. BAL is not given by intravenous injection. [JMNMCH] 3. Presence of an abnormal ATP7B gene causes chronic copper poisoning. [GDIMSH] 4. Arsenic was historically used as a homicidal poison. [TGMCH]

Reading File
Topics identified: SAQ Group B covers Arsenic poisoning (Q1, Q3, Q4), Lead poisoning (Q2), Aluminium Phosphide / Phosphine poisoning (Q5 - tablets for grain storage). Group D covers lead, BAL, Wilson's disease, arsenic ML aspects. Let me search all in parallel.
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Found the ALP section. Let me read it in parallel with the arsenic autopsy findings section:
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the information needed to answer every question comprehensively. Let me compile the complete answers.

GROUP B (SAQ - 10 Marks Each) & GROUP D (Essay/Write-up - 4 Marks Each)


SAQ Q1 (IQCITY) - Acute loss of hair + garlicky odour + rice water stools [1+3+3+2+1 = 10]

a. Identify the Poison (1 mark)

Arsenic Poisoning (most likely acute/subacute arsenic trioxide or pesticide containing arsenic such as Paris green)
The classic triad:
  • Acute hair loss (alopecia) - arsenic concentrates in keratin-rich tissues
  • Garlicky odour from mouth - characteristic of arsenic
  • Rice-water stools - profuse watery diarrhea from capillary transudation through intestinal mucosa

b. Clinical Features (3 marks)

Acute Arsenic Poisoning - symptoms begin within 30 minutes of ingestion:
Gastrointestinal Phase:
  1. Metallic/garlic taste + dry mouth (xerostomia) + dysphagia
  2. Severe nausea and projectile vomiting (dark brown/yellow, contains blood)
  3. Burning pain and throat constriction
  4. Intense thirst; excessive salivation
  5. Profuse diarrhea - stools initially high-colored/bloody, later colorless, odourless, watery rice-water stools (from capillary transudation through ruptured vesicles under intestinal mucosa)
  6. Tenesmus and irritation around anus
  7. Colicky abdominal pain increasing on pressure
Systemic Phase (if large dose): 8. Dehydration - shrunken eyes, cold clammy skin, pale/anxious face 9. Generalised vasodilation → plasma transudation → hypovolemia → circulatory shock 10. Calf muscle cramps; restlessness 11. Oliguria, proteinuria, haematuria (renal tubular necrosis) 12. Cyanosis of hands and feet 13. Cardiac: acute cardiomyopathy, ECG changes (T-wave inversion, prolonged QT interval) 14. CNS: hypoxic encephalopathy, convulsions, coma → death 15. Hyperpyrexia and acute haemolysis
Secondary effects (2-4 weeks after sublethal dose):
  • Acute hair loss (alopecia)
  • Mee's lines - transverse white lines on nails (1-2 mm wide, seen 5 weeks after exposure; multiple lines with multiple exposures)
  • Sensorimotor peripheral neuropathy (glove and stocking pattern)
  • Skin pigmentation and hyperkeratosis

Treatment (3 marks)

  1. Remove from source of exposure
  2. Decontamination:
    • Empty stomach by emetics (tartar emetic and copper sulphate NOT to be used)
    • Gastric lavage with freshly prepared ferric hydroxide (ferric oxide) in water - forms insoluble ferric arsenite
    • Alternatively: 1% sodium thiosulphate solution for gastric lavage
    • Castor oil or MgSO₄ (cathartic) to diminish intestinal absorption
  3. Specific Antidote - Chelation:
    • BAL (Dimercaprol): Drug of choice. 2.5-3 mg/kg IM, 4-hourly for first 2 days, 6-hourly for 1 day, then 12-hourly until recovery. Stop if urine arsenic falls below 50 μg/24 hours after 5 days, then restart.
    • Oral Penicillamine: 100 mg/kg/day in 4 divided doses for 4-8 days after initial BAL therapy
    • DMSA (Succimer): 10 mg/kg TDS (safer alternative)
    • NOTE: BAL is NOT effective in arsine gas poisoning
  4. Supportive:
    • IV saline for dehydration and shock
    • Morphine for pain relief
    • Demulcents - ghee, barley water
    • Vitamin B1 (thiamine) for peripheral neuritis
    • Massage for cramps; maintain body temperature
  5. For arsine gas poisoning specifically: Fresh air, oxygen, exchange transfusion, hemodialysis, alkaline drinks (BAL NOT effective)

Postmortem Findings (2 marks)

External:
  1. Rigor mortis lasts longer than usual
  2. General shrunken appearance due to dehydration
  3. Shrunken eyeballs
  4. Cyanosis of hands and feet
  5. Jaundice (yellowish skin discoloration)
Internal: 6. Mucous membrane of mouth and pharynx - inflamed and ulcerated 7. Stomach - inner wall swollen, congested, brownish-red or scarlet; petechial haemorrhages; inflamed with blood-streaked mucosa mixed with arsenic; inflammation maximal at greater curvature and cardiac end; ulceration (rarely: gangrene, perforation) 8. Small intestine - flabby, contains large flakes of mucus; submucosal haemorrhages; epithelium oedematous 9. Large intestine - contains seromucous material; swollen glands 10. Lungs - congested, oedematous, subpleural ecchymoses 11. Liver - enlarged, fatty/yellow (centrizonal necrosis); cirrhosis in chronic 12. Kidneys - congested; tubular necrosis 13. Body is well preserved (arsenic has antiseptic properties; delays putrefaction) - classic in exhumed bodies
Special finding: Arsenic detectable in hair and nails even years after death (high affinity for keratin). By segmental hair analysis, the timeline of exposure can be reconstructed.

c. Medico-Legal Aspects (1 mark)

  1. Ideal homicidal poison in India - tasteless, odourless, easily available, inexpensive; mixed with sweets, cooked vegetables, milk, drinks; mass homicidal poisoning mimics cholera
  2. Advantages as homicidal poison to the poisoner are nullified by:
    • Detectable even in charred and decomposed bodies
    • Delays putrefaction (antiseptic effect)
    • Detected in bones, hair, nails years after death
    • By segmental hair analysis (dividing hair from root upward), exact time of each exposure can be determined
  3. Used on abortion sticks (abortifacient); as cattle poison in wells
  4. Used for suicidal purposes; accidentally from improper medicinal use (Fowler's solution - 1% arsenious trioxide), vaginal pessaries, skin application for impotency
  5. Arsenophagists - persons who take arsenic habitually (for impotency treatment) can develop tolerance
  6. Beer drinkers in Lancashire (1900) - mass arsenic poisoning causing peripheral neuritis (from arsenic-contaminated brewing)

SAQ Q2 (ICARE) - Unconscious male, blue line between teeth and gum [1+6+3 = 10]

Probable Diagnosis (1 mark)

Chronic Lead Poisoning (Plumbism) - Lead Line (Burtonian Line) between teeth and gum is the pathognomonic finding.

Management (6 marks)

Step 1 - Initial Stabilisation (ABCs):
  • Airway management (patient is unconscious - secure airway, intubate if needed)
  • IV access, monitor vitals, oxygen supplementation
  • Blood glucose, ECG monitoring
Step 2 - Investigations to guide management:
  • Blood lead level (BLL): normal 0.03 mg/100 mL; clinical symptoms at >70 μg/100 mL
  • CBC - look for basophilic stippling, anaemia
  • Urine - ALA, coproporphyrin III, urine lead
  • RFTs, LFTs, electrolytes, blood gas
  • Peripheral blood smear: basophilic stippling confirms diagnosis
Step 3 - Remove from Source:
  • Remove from occupational/industrial exposure immediately
Step 4 - Decontamination:
  • Gastric lavage with 1% MgSO₄ or Na₂SO₄
  • MgSO₄/Na₂SO₄ orally to convert unabsorbed lead to insoluble lead sulphate
Step 5 - Chelation Therapy (as this patient is unconscious = likely lead encephalopathy; BLL presumed >70 μg/100 mL):
Severe acute lead poisoning with encephalopathy (BAL + EDTA combination):
  • BAL (Dimercaprol): 4 mg/kg IM every 4 hours. Give AT LEAST 4 hours BEFORE EDTA. Chelates lead both intracellularly and extracellularly. Two BAL molecules bind one lead atom → excreted in bile and urine. Drug of choice when renal function is impaired.
  • CaNa₂EDTA (Calcium Disodium Versenate): 75 mg/kg/day IV infusion (dilute 5 mL of 20% solution in 500 mL NS/5%D, slow IV drip twice daily × 5 days). Increases urinary lead excretion 50-fold. Reduce to 50 mg/kg/day as condition improves.
  • Continue until patient is asymptomatic and BLL <40 μg/100 mL
  • Then switch to oral: DMSA (Succimer) 10 mg/kg TDS × 20 days, OR D-penicillamine 10 mg/kg/day
Step 6 - Supportive Treatment:
  • Manage cerebral oedema: mannitol, dexamethasone
  • Anticonvulsants for seizures (diazepam IV, phenobarbitone)
  • Calcium gluconate IV (10-20 mL of 10%) - relieves colic
  • High calorie diet + milk (3 pints/day) - induces alkalosis → fixes lead in bones
  • Thiamine 10-50 mg/kg - improves neurological manifestations
  • Monitor BP, urine output, renal function, serial BLL
Step 7 - Prevention of Recurrence:
  • Occupational hygiene, workplace ventilation
  • Regular periodic medical surveillance of all workers
  • Notify as occupational disease (notifiable + compensatable in India since 1924)

Other Poisons Causing a Blue/Dark Line on Gums (3 marks)

The blue/dark line on gums is caused by subepithelial deposition of metal sulphide due to action of H₂S from mouth bacteria on absorbed metal:
Metal/PoisonColour of LineNotes
LeadBlue-black (Burtonian line)Most classic; lead sulphide
MercuryBluish-blackMercury sulphide at gum margin
CopperGreenish-blueCopper sulphide
BismuthBlue-blackBismuth sulphide
SilverBluish-grey (Argyria)Silver sulphide; also generalised skin pigmentation
IronDark lineIron sulphide
Memory tip: Lead-Mercury-Copper-Bismuth-Iron-Silver = "Let Me Come Back In Silver"
Key differentiating points for the lead line specifically:
  • Seen in 50-70% of lead poisoning cases
  • Only near dirty/carious teeth, specifically the upper jaw gingival margin
  • Appears within 1 week of exposure
  • Chemical basis: Lead sulphide (PbS) formed by H₂S from decomposed food

SAQ Q3 (GDIMSH) - Calico printing worker: abdominal pain, tingling, hard wart-like growths on palms/soles [1+5+4 = 10]

i. Probable Poison (1 mark)

Chronic Arsenic Poisoning
Calico printing industry uses arsenic-containing dyes (copper arsenite / Paris green). The multiple hard wart-like keratoses on palms and soles (arsenical keratosis/hyperkeratosis) is pathognomonic of chronic arsenic exposure.

ii. Signs and Symptoms of Chronic Arsenic Poisoning (5 marks)

Chronic arsenic poisoning progresses through four stages:
First Stage:
  • Loss of weight, loss of appetite, excessive salivation
  • Colicky pain and constipation (or diarrhea/vomiting)
  • Soft, red gums; coated tongue (thin white/silvery)
  • Oedema of eyelids and ankles
  • Raised temperature and pulse
Second Stage - Cutaneous Changes:
  • Erythematous flushing (earliest skin change from capillary dilation)
  • "Rain-drop" pigmentation - generalized or localized, patchy/diffuse hyperpigmentation involving covered parts (flexures, nipples, lower abdomen, temples, eyelids). Distinguished from Addison's disease - oral mucosa is SPARED
  • Hyperkeratosis - discrete multiple wart-like keratoses on palms, soles, head, trunk
  • Bowen's disease (intraepidermal carcinoma) and basal cell carcinoma - 20% develop epitheliomata
  • Dry, brittle, cracked nails with linear pigmentation
  • Dry hair that falls (alopecia)
  • Mee's lines - transverse white lines (1-2 mm) on nail plate, 5 weeks after exposure
  • Catarrh of larynx and bronchial tubes; hoarse voice
  • Photophobia, conjunctivitis, running nose, cough with bloody expectoration
  • Liver enlarged and cirrhotic; renal damage
  • Painless perforation of nasal septum
Third Stage - Neuropathic:
  • Sensory symptoms: headache, tingling, numbness, hyperaesthesia
  • Tenderness and muscle cramps
  • Circumscribed oedema of eyelids and ankles
  • Knee jerks lost
  • Impotence
  • Bone marrow depression and aplastic changes
Fourth Stage - Advanced Neuropathy:
  • Peripheral neuritis with "glove and stocking" anaesthesia (decreased pain, temperature, touch)
  • Symmetrical sensorimotor polyneuropathy (resembles Guillain-Barre syndrome)
  • Muscular atrophy of extensor muscles → wrist drop and foot drop
  • Muscular weakness, ataxia, cramps, tremors
  • General emaciation
  • Anaemia, dysuria
  • Encephalopathy: headache, personality disturbance, convulsions, coma
  • Death due to failure of heart muscles

iii. Disease Mimicked by Acute Arsenic Poisoning + Differentiating Features (4 marks)

Acute arsenic poisoning mimics CHOLERA (Asiatic cholera)
Both present with profuse watery diarrhoea, vomiting, dehydration, and collapse.
Differential Diagnosis Table:
FeatureAcute Arsenic PoisoningCholera
CauseChemical poisonVibrio cholerae infection
Pain in throatPresent BEFORE vomitingPresent AFTER vomiting
SequenceVomiting PRECEDES purgingPurging PRECEDES vomiting
VomitusConsists of mucus, bile, and bloodWatery (rice-water)
StoolsHigh-coloured, discharged with straining and tenesmus; later rice-waterRice-water, involuntary, without straining
VoiceNot affectedPeculiar and rough (vox cholerica)
ConjunctivitisPresent (inflamed)Not inflamed
Garlicky odourPresentAbsent
Other historyPossible ingestion history; occupational/poisoning contextEpidemic setting; cholera contact
TenesmusPresentUsually absent
LabArsenic in urine/blood/hairStool culture positive for V. cholerae
Response to treatmentPoor response to ORS aloneGood response to ORS/rehydration

SAQ Q4 (BSMCH) - Intense thirst, vomiting, purging with tenesmus, garlicky breath [1+4+2+3 = 10]

i. Probable Diagnosis (1 mark)

Acute Arsenic Poisoning
Classic features: intense thirst + severe vomiting + purging with tenesmus + irritation around anus + garlicky odour from breath.

ii. Treatment (4 marks)

(Refer to Q1 treatment above for full detail)
Summary:
  1. Remove from source; empty stomach - gastric lavage with freshly prepared ferric hydroxide in water (forms insoluble ferric arsenite); alternatively 1% sodium thiosulphate
  2. MgSO₄ or castor oil as cathartic
  3. BAL (Dimercaprol): 2.5-3 mg/kg IM, q4h × 2 days → q6h × 1 day → q12h; stop when urine arsenic <50 μg/24 hours for 5 days, then restart
  4. Oral Penicillamine: 100 mg/kg/day in 4 divided doses for 4-8 days after BAL
  5. IV saline - fluid replacement for dehydration and shock; 4-6 L in first few hours
  6. Morphine for pain; demulcents (ghee, barley water); massage for cramps
  7. Monitor vitals, urine output, cardiac monitoring (ECG for QT prolongation)

iii. Circumstances of Poisoning (2 marks)

  1. Homicidal (most common in India): Arsenic is the ideal homicidal poison - tasteless, odourless, cheap, easily available. Mixed with food, sweets, milk, drinks. Mass poisoning mimics cholera, making detection difficult.
  2. Suicidal: Used deliberately as a suicidal agent (less common than homicidal)
  3. Accidental:
    • Improper medicinal use (Fowler's solution - 1% arsenious trioxide)
    • Mistaken for baking powder or soda and mixed into food
    • Accidental use as vaginal pessaries
    • Application on abraded skin (for impotency cure)
    • Occupational (calico printing, smelting, pesticide manufacturing)
    • Environmental (well contaminated with arsenic for cattle poison)
  4. Arsenophagists: Habitual arsenic users (for impotency); can develop tolerance over time.

iv. Natural Disease Simulating Arsenic Poisoning + Differentiation (3 marks)

(See the cholera differentiation table in Q3 - iii above)
Cholera is the classic mimic. Additional differentiation:
  • Cholera is epidemic/endemic; arsenic is usually a solitary case
  • Cholera: El Tor/classical V. cholerae isolated from stool culture
  • Cholera: no garlicky breath, no tenesmus, no blood in stools
  • Arsenic: ECG changes (QT prolongation), jaundice, renal failure - not seen in cholera
  • Arsenic: hair and nail changes (Mee's lines) in survivors

SAQ Q5 (TGMCH) - Tablets kept for grain storage, garlicky breath, shock, ARDS [2+2+2+2+2 = 10]

A. Identify the Poison + Active Toxic Principle (2 marks)

Poison: Aluminium Phosphide (ALP) - commonly known as Celphos, Alphos, Quickphos, Phostoxin, Phosphotex
  • Gray-green tablet, 3 g each; mixed with urea and ammonium carbonate
  • Widely used as grain fumigant (grain preservative in food storage)
  • Available OTC, cheap, easily accessible - frequently used suicidally and homicidally in India
Active Toxic Principle: Phosphine gas (PH₃)
  • Each tablet liberates 1 gram of phosphine on contact with moisture/HCl in stomach
  • Fatal dose: 1-3 g (1-3 tablets); 1-2 g is lethal
  • Fatal period: 6-12 hours (majority of deaths within 24 hours)
  • ALP has a garlicky odour

B. Mechanism of Toxicity (2 marks)

Chemical Reaction:
AlP + 3H₂O → Al(OH)₃ + PH₃ (phosphine gas)
The reaction is accelerated by HCl in stomach.
Mechanism of phosphine toxicity:
  1. Inhibits cytochrome oxidase (preferential inhibition) → disrupts the mitochondrial electron transport chain → cellular hypoxia
  2. Inhibits respiratory chain enzymes → cytotoxic action on all organs
  3. Systemic poison - affects all organs: heart, lungs, liver, kidney, CNS
  4. Phosphine absorbed: Rapidly absorbed from GI tract by simple diffusion + inhaled from lungs; metabolized in liver (slow release of phosphine) - accounts for prolonged symptoms
  5. Excreted as hypophosphite in urine; unchanged form through lungs
Key consequence: The most lethal effect is cardiogenic shock from direct myocardial toxicity (acute congestive heart failure is the most common cause of death).

C. Clinical Features + Complications (2+2 = 4 marks)

Clinical Features (by system):
GI:
  • Nausea, severe vomiting, burning epigastric pain
  • Intense thirst, diarrhea
  • Garlicky (fishy) odour from breath
Respiratory:
  • Tightness in chest, dyspnoea, cough, cyanosis
  • Pulmonary oedema
  • Respiratory failure (ARDS)
Cardiovascular:
  • ECG abnormalities: sinus tachycardia, bradycardia, heart block, arrhythmias
  • Hypotension, shock
  • Myocardial damage, acute cardiomyopathy, pericarditis
  • Congestive cardiac failure
  • Cardiogenic shock - most common cause of death
CNS:
  • Restlessness, headache, dizziness
  • Altered sensorium, convulsions
  • Acute hypoxic encephalopathy, coma
Metabolic:
  • Hypocalcaemia → tetany
  • Metabolic acidosis
Hepatic/Renal:
  • Jaundice, hepatitis, hepatomegaly
  • Acute renal failure (oliguria)
Other:
  • Cold, clammy skin in terminal stages
  • Rare: muscle wasting, bleeding diathesis, acute massive GI bleeding
Complications:
  1. Cardiogenic shock (most common cause of death)
  2. ARDS (Adult Respiratory Distress Syndrome)
  3. Acute congestive cardiac failure
  4. Acute pericarditis
  5. Acute massive GI bleeding
  6. Multi-organ failure (MOF)
  7. Mortality rate: 35-100% (very high)

D. Management (2 marks)

There is NO specific antidote for ALP poisoning - treatment is supportive.
  1. Gastric lavage with potassium permanganate (after endotracheal intubation) - oxidizes phosphine to non-toxic phosphate; repeat 2-3 times
  2. Activated charcoal 100 g orally mixed with sorbitol (NOT water) to adsorb phosphine
  3. Antacids - reduce GI symptoms and reduce phosphine absorption
  4. Liquid paraffin - promotes excretion of ALP and phosphine from gut
  5. IV Fluids: 4-6 litres in first 3-6 hours (50% normal saline) to treat shock
  6. Magnesium sulphate: 1 g IV stat, repeat q2h × 2 doses, then 1-1.5 g IV q6h × 5-7 days (corrects hypomagnesemia, reduces organ toxicity, treats arrhythmias)
  7. Low-dose dopamine: 4-6 μg/kg/min IV (for cardiogenic shock)
  8. IV Hydrocortisone: 400 mg IV q4-6 hours (highly effective; reduces dopamine requirement)
  9. Oxygen for hypoxia
  10. Sodium bicarbonate IV to correct metabolic acidosis
  11. Peritoneal dialysis or hemodialysis
  12. ECG monitoring + manage arrhythmias
Diagnosis tip: Silver nitrate test on filter paper - patient breathes through AgNO₃-impregnated paper for 5-10 minutes → paper turns black (silver reduced by phosphine) = confirmatory test for phosphine.

GROUP D - Essay/Write-up Questions (4 marks each)


D1. "Foot drop and Burtonian line are features of chronic lead poisoning" (MLDMCH)

This statement is TRUE.
Burtonian Line (Lead Line):
  • A blue/bluish-black stippled line on the gum margin, seen in 50-70% of chronic lead poisoning cases
  • Located at the junction of teeth and gums, particularly near dirty or carious teeth, predominantly upper jaw
  • Appears within 1 week of significant lead exposure
  • Mechanism: Lead absorbed into blood is deposited subepithelially in the gingival margin; reacts with H₂S produced by decomposed food bacteria in the mouth → forms lead sulphide (PbS), which appears as the dark blue line
  • It is a useful clinical diagnostic sign at lead blood levels of 60-80 μg/100 mL
Foot Drop:
  • A manifestation of lead palsy (late feature, <10% of cases)
  • Lead causes peripheral motor neuropathy specifically targeting muscle groups prone to fatigue
  • The anterior tibial muscles are affected → failure of dorsiflexion of foot = foot drop
  • Mechanism: (i) interference with phosphocreatine metabolism; (ii) peripheral axonal neuropathy - axonal degeneration from toxic action of lead on anterior horn cells
  • It is a purely motor paralysis (no sensory loss initially)
  • Other muscles affected: wrist extensors (wrist drop - most common), deltoid, biceps; rarely eye muscles
  • Tremors, cramps, numbness, hyperesthesia PRECEDE the actual motor weakness
  • Recovery may be complete but is characteristically slow
Conclusion: Both foot drop and Burtonian line are well-established, classical features of chronic lead poisoning (plumbism), seen in workers with prolonged occupational exposure (e.g., paint, battery, printing industries). The combination is virtually pathognomonic of the condition.

D2. "BAL is not given by intravenous injection" (JMNMCH)

This statement is TRUE - BAL (British Anti-Lewisite / Dimercaprol) is NEVER given intravenously.
Why BAL cannot be given IV:
  1. Local tissue toxicity: BAL is an oily preparation dissolved in peanut oil (benzyl benzoate) - it is not water soluble and cannot be safely administered as an IV preparation
  2. Systemic side effects at IV concentrations: If given IV, it would produce immediate and severe systemic reactions including:
    • Acute hypertensive crisis (severe rise in blood pressure)
    • Tachycardia and palpitations
    • Burning sensation in mouth, throat, and eyes
    • Nausea, vomiting
    • Constriction in the throat
    • Hypotension (paradoxically, at higher doses)
    • Lacrimation, rhinorrhea, salivation
    • Severe headache and anxiety
    • Risk of haemolysis
  3. Proper route: BAL is always given by deep intramuscular (IM) injection (preferably into the gluteal region). This route allows slower absorption with better local tolerance.
  4. Dose: Standard dose is 3-4 mg/kg IM every 4-6 hours for the first 2 days, then tapering over 7-10 days
Clinical uses where BAL is the chelator of choice:
  • Lead poisoning (especially with encephalopathy)
  • Arsenic poisoning
  • Mercury poisoning
  • Gold toxicity
  • Antimony and bismuth poisoning
  • Preferred when renal function is impaired (excretes lead-BAL complex via bile)
Note: BAL should always be given at least 4 hours BEFORE CaNa₂EDTA in lead poisoning, as EDTA mobilizes lead from tissues which can aggravate symptoms of lead poisoning if given before BAL chelates the mobilized lead.

D3. "Presence of an abnormal ATP7B gene causes chronic copper poisoning" (GDIMSH)

This statement is TRUE - the abnormal ATP7B gene is responsible for Wilson's disease, which represents a form of chronic endogenous copper toxicosis.
ATP7B gene and Wilson's Disease:
  • ATP7B encodes a copper-transporting P-type ATPase (ATPase type 7B), located primarily in hepatocytes
  • This enzyme is responsible for:
    1. Incorporating copper into ceruloplasmin (the major copper transport protein in blood)
    2. Excreting excess copper into bile (the primary route of copper elimination)
  • Mutation: Wilson's disease is an autosomal recessive disorder caused by mutation/defect in the ATP7B gene (chromosome 13q14.3)
  • Result of abnormal gene:
    • Defective biliary excretion of copper → copper accumulates in hepatocytes
    • Deficient copper incorporation into ceruloplasmin → low serum ceruloplasmin
    • Copper overflows from liver into blood → deposits in other organs
Organs affected (chronic copper toxicosis):
OrganManifestation
LiverHepatitis → Cirrhosis → Liver failure
Brain (basal ganglia)Neuropsychiatric: dysarthria, tremors, rigidity, chorea, personality change, psychosis
EyesKayser-Fleischer rings - golden-brown rings at Descemet's membrane of cornea (pathognomonic)
KidneysFanconi syndrome (proximal tubular dysfunction) - glycosuria, aminoaciduria
BloodHaemolytic anaemia (from copper toxicity to RBCs)
BonesOsteoporosis, arthropathy
Diagnosis: Serum ceruloplasmin (<20 mg/dL), 24-hour urine copper (>100 μg/day), slit-lamp examination (KF rings), liver biopsy (copper >250 μg/g dry weight), ATP7B gene analysis
Treatment: Copper chelation with D-penicillamine (first line), trientine (second line); zinc acetate (reduces intestinal copper absorption); liver transplantation in fulminant cases
Summary: The ATP7B gene mutation causes failure of copper excretion from the body → chronic, progressive, endogenous copper poisoning = Wilson's disease. This is a paradigm of genetic heavy metal toxicosis.

D4. "Arsenic was historically used as a homicidal poison" (TGMCH)

This statement is TRUE - arsenic has a long and well-documented history as the preeminent homicidal poison, earning it the title "King of Poisons" and "Poison of Kings."
Historical Background:
  • Arsenic trioxide (As₂O₃) was known as "inheritance powder" (poudre de succession) in medieval Europe, used to hasten inheritance by eliminating inconvenient relatives
  • Named "King of Poisons" because it was undetectable by the primitive chemical methods of earlier eras
  • Widely used in 18th-19th century Europe by poisoners, particularly in France and Italy
Properties making it ideal as a homicidal poison:
  1. Tasteless and odourless - easily mixed with food, drinks, sweets, cooked vegetables, milk without detection
  2. Slow-acting - in small doses, mimics natural disease (gastroenteritis, cholera) - death appears natural
  3. Easily available - historically sold as rat poison, pesticide; used in paints, dyes, cosmetics
  4. Inexpensive - accessible to common people
  5. Small dose required - fatal dose as low as 30 mg (arsenic trioxide)
  6. Mass poisoning capability - mass homicidal poisoning simulates cholera epidemic
Famous historical cases:
  • Napoleon Bonaparte - suspected arsenic poisoning (high arsenic found in his hair on exhumation)
  • Marie Lafarge case (France, 1840) - first case where Marsh's test was used in forensic detection
  • Charles Francis Hall (Arctic explorer) - alleged arsenic poisoning
  • Multiple Victorian-era "wife poisoners"
Modern forensic relevance (why detection is now possible):
  1. Marsh's test (1836) and Reinsch's test - classic chemical tests
  2. Atomic absorption spectroscopy (AAS) - highly sensitive quantitative detection
  3. Neutron activation analysis - can detect arsenic in hair, nails even in decomposed/exhumed bodies
  4. Segmental hair analysis - determines timing of poisoning (arsenic deposits in hair at rate of 1 cm/month)
  5. Body preservation - arsenic delays putrefaction, enabling delayed forensic examination
In India specifically:
  • Arsenic remains a significant forensic problem due to ready availability of arsenic-based pesticides
  • Used homicidally in domestic settings, mixed with food
  • Medico-legally significant as it is very difficult to detect clinically until late stages
Disadvantages (for the poisoner):
  • Detectable even in charred and decomposed bodies
  • Can be found in bones, hair, nails years after death
  • Delays putrefaction (body preserved longer - more time for detection)
  • Modern toxicological methods are highly sensitive
Conclusion: Arsenic's historical dominance as a homicidal poison is well-established. The development of Marsh's test in 1836 - the world's first quantitative forensic toxicological test - was specifically to detect arsenic, reflecting its prevalence as a criminal poison. While modern forensics has largely removed its "undetectable" advantage, arsenic poisoning remains medico-legally relevant today.

Sources: PC Dikshit Textbook of Forensic Medicine and Toxicology | The Essentials of Forensic Medicine and Toxicology, 36th ed. (KS Narayana Reddy, 2026) | Park's Textbook of Preventive and Social Medicine
This is a shared conversation. Sign in to Orris to start your own chat.